Charles River Laboratories International, Inc. (CRL)
298.58
+3.39
(+1.15%)
USD |
NYSE |
Aug 24, 16:00
298.74
+0.16
(+0.05%)
After-Hours: 20:00
Charles River Laboratories International Debt to Equity Ratio : 1.069 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.069 |
| March 31, 2026 | 1.042 |
| December 31, 2025 | 0.8315 |
| September 30, 2025 | 0.7727 |
| June 30, 2025 | 0.8317 |
| March 31, 2025 | 0.9358 |
| December 31, 2024 | 0.8034 |
| September 30, 2024 | 0.7304 |
| June 30, 2024 | 0.7632 |
| March 31, 2024 | 0.8464 |
| December 31, 2023 | 0.8693 |
| September 30, 2023 | 0.8794 |
| June 30, 2023 | 0.9484 |
| March 31, 2023 | 1.019 |
| December 31, 2022 | 1.058 |
| September 30, 2022 | 1.276 |
| June 30, 2022 | 1.290 |
| March 31, 2022 | 1.142 |
| December 31, 2021 | 1.165 |
| September 30, 2021 | 1.307 |
| June 30, 2021 | 1.295 |
| March 31, 2021 | 1.101 |
| December 31, 2020 | 1.022 |
| September 30, 2020 | 1.153 |
| June 30, 2020 | 1.388 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.532 |
| December 31, 2019 | 1.239 |
| September 30, 2019 | 1.340 |
| June 30, 2019 | 1.513 |
| March 31, 2019 | 1.216 |
| December 31, 2018 | 1.266 |
| September 30, 2018 | 1.344 |
| June 30, 2018 | 1.546 |
| March 31, 2018 | 0.9938 |
| December 31, 2017 | 1.096 |
| September 30, 2017 | 1.158 |
| June 30, 2017 | 1.187 |
| March 31, 2017 | 1.366 |
| December 31, 2016 | 1.476 |
| September 30, 2016 | 1.451 |
| June 30, 2016 | 1.642 |
| March 31, 2016 | 1.105 |
| December 31, 2015 | 1.177 |
| September 30, 2015 | 1.210 |
| June 30, 2015 | 1.101 |
| March 31, 2015 | 1.185 |
| December 31, 2014 | 1.157 |
| September 30, 2014 | 1.174 |
| June 30, 2014 | 1.211 |
| March 31, 2014 | 0.9214 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IQVIA Holdings, Inc. | 2.632 |
| Medpace Holdings, Inc. | 0.3322 |
| Fortrea Holdings, Inc. | 2.132 |
| Avantor, Inc. | 0.6568 |
| Champions Oncology, Inc. | 1.167 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.532B |
| Total Liabilities (Quarterly) | 4.644B |
| Shareholders Equity (Quarterly) | 2.840B |
| Current Ratio | 1.348 |
| Net Debt Paydown Yield | -0.08% |